Literature DB >> 14682491

Naturally arising CD25+CD4+ regulatory T cells in maintaining immunologic self-tolerance and preventing autoimmune disease.

Takeshi Takahashi1, Shimon Sakaguchi.   

Abstract

A large body of evidence indicates that T cell-mediated dominant suppression of self-reactive T cells is indispensable for maintaining immunologic unresponsiveness to self-constituents (i.e., self-tolerance) and preventing autoimmune disease. CD25+CD4+ regulatory T cells naturally present in normal animals, in particular, engage in this function, as their reduction or functional abnormality leads to the development of autoimmune disease in otherwise normal animals. They are at least in part produced by the normal thymus as a functionally mature and distinct subpopulation of T cells. Recent studies have demonstrated that CD25+CD4+ regulatory T cells control not only autoimmune reactions but also other immune responses, including tumor immunity, transplantation tolerance and microbial infection. Thus, this unique population of regulatory T cells can be exploited to control pathological as well as physiological immune responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14682491     DOI: 10.2174/1566524033479429

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  19 in total

Review 1.  An immunology primer for computational modelers.

Authors:  William F Hawse; Penelope A Morel
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-09-20       Impact factor: 2.745

Review 2.  Retinoic acid in the immune system.

Authors:  Karina Pino-Lagos; Micah J Benson; Randolph J Noelle
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

3.  Immunoregulation through IL-10 gene expression and the fate of cytotoxic T lymphocyte-mediated tumor immunotherapy.

Authors:  Nitya G Chakraborty
Journal:  Indian J Hum Genet       Date:  2009-01

4.  Immune modulation induced by tuberculosis DNA vaccine protects non-obese diabetic mice from diabetes progression.

Authors:  R Rodrigues dos Santos Júnior; A Sartori; V L Deperon Bonato; A A M Coelho Castelo; C A Vilella; R L Zollner; C Lopes Silva
Journal:  Clin Exp Immunol       Date:  2007-06-22       Impact factor: 4.330

Review 5.  Manipulation of regulatory T cells and antigen-specific cytotoxic T lymphocyte-based tumour immunotherapy.

Authors:  Shirin Karimi; Subhasis Chattopadhyay; Nitya G Chakraborty
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

Review 6.  DNA vaccines to attack cancer.

Authors:  Freda K Stevenson; Christian H Ottensmeier; Peter Johnson; Delin Zhu; Sarah L Buchan; Katy J McCann; Joanne S Roddick; Andrew T King; Feargal McNicholl; Natalia Savelyeva; Jason Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-03       Impact factor: 11.205

7.  Chloroquine treatment enhances regulatory T cells and reduces the severity of experimental autoimmune encephalomyelitis.

Authors:  Rodolfo Thomé; Adriel S Moraes; André Luis Bombeiro; Alessandro dos Santos Farias; Carolina Francelin; Thiago Alves da Costa; Rosária Di Gangi; Leonilda Maria Barbosa dos Santos; Alexandre Leite Rodrigues de Oliveira; Liana Verinaud
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

Review 8.  Immunological ignorance of solid tumors.

Authors:  Adrian F Ochsenbein
Journal:  Springer Semin Immunopathol       Date:  2005-01-27

9.  Association Between FSIP2 Mutation and an Improved Efficacy of Immune Checkpoint Inhibitors in Patients With Skin Cutaneous Melanoma.

Authors:  Haoxuan Ying; Anqi Lin; Junyi Liang; Jian Zhang; Peng Luo
Journal:  Front Mol Biosci       Date:  2021-05-24

10.  Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides - preclinical and clinical data.

Authors:  Ana M Vázquez; Ana M Hernández; Amparo Macías; Enrique Montero; Daniel E Gómez; Daniel F Alonso; Mariano R Gabri; Roberto E Gómez
Journal:  Front Oncol       Date:  2012-10-23       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.